These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 23628554)

  • 1. Down-regulation of signal transducer and activator of transcription 3 improves human acute myeloid leukemia-derived dendritic cell function.
    Brady MT; Miller A; Sait SN; Ford LA; Minderman H; Wang ES; Lee KP; Baumann H; Wetzler M
    Leuk Res; 2013 Jul; 37(7):822-8. PubMed ID: 23628554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Interferon (IFN)α in "Cocktails" for the Generation of (Leukemia-derived) Dendritic Cells (DCleu) From Blasts in Blood From Patients (pts) With Acute Myeloid Leukemia (AML) and the Induction of Antileukemic Reactions.
    Hirn Lopez A; Deen D; Fischer Z; Rabe A; Ansprenger C; Stein K; Vogt V; Schick J; Kroell T; Kraemer D; Kolb HJ; Tischer J; Schmid C; Schmetzer H
    J Immunother; 2019 Jun; 42(5):143-161. PubMed ID: 31090655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide affects signal transducer and activator of transcription proteins through alteration of protein tyrosine kinase phosphorylation.
    Wetzler M; Brady MT; Tracy E; Li ZR; Donohue KA; O'Loughlin KL; Cheng Y; Mortazavi A; McDonald AA; Kunapuli P; Wallace PK; Baer MR; Cowell JK; Baumann H
    Clin Cancer Res; 2006 Nov; 12(22):6817-25. PubMed ID: 17121903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of acute and chronic myeloid leukemic blasts into the dendritic cell lineage: analysis of various differentiation-inducing signals.
    Kharfan-Dabaja M; Ayala E; Lindner I; Cejas PJ; Bahlis NJ; Kolonias D; Carlson LM; Lee KP
    Cancer Immunol Immunother; 2005 Jan; 54(1):25-36. PubMed ID: 15693136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemia blast-induced T-cell anergy demonstrated by leukemia-derived dendritic cells in acute myelogenous leukemia.
    Narita M; Takahashi M; Liu A; Nikkuni K; Furukawa T; Toba K; Koyama S; Takai K; Sanada M; Aizawa Y
    Exp Hematol; 2001 Jun; 29(6):709-19. PubMed ID: 11378266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of heat shock protein 70 improves arsenic trioxide and 17-DMAG effects on constitutive signal transducer and activator of transcription 3 activity.
    Ghoshal S; Rao I; Earp JC; Jusko WJ; Wetzler M
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):681-9. PubMed ID: 20035426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved effector function of leukemia-specific T-lymphocyte clones trained with AML-derived dendritic cells.
    Schuster FR; Buhmann R; Reuther S; Hubner B; Grabrucker C; Liepert A; Reibke R; Lichtner P; Yang T; Kroell T; Kolb HJ; Borkhardt A; Schmetzer H
    Cancer Genomics Proteomics; 2008; 5(5):275-86. PubMed ID: 19129558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro induction of a dendritic cell phenotype in primary human acute myelogenous leukemia (AML) blasts alters the chemokine release profile and increases the levels of T cell chemotactic CCL17 and CCL22.
    Olsnes AM; Ryningen A; Ersvaer E; Bruserud Ø
    J Interferon Cytokine Res; 2008 May; 28(5):297-310. PubMed ID: 18547160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD200 on AML blasts directly suppresses memory T-cell function.
    Coles SJ; Hills RK; Wang EC; Burnett AK; Man S; Darley RL; Tonks A
    Leukemia; 2012 Sep; 26(9):2148-51. PubMed ID: 22430635
    [No Abstract]   [Full Text] [Related]  

  • 10. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
    Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
    Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Vγ9Vδ2 T cells specifically recognize and kill acute myeloid leukemic blasts.
    Gertner-Dardenne J; Castellano R; Mamessier E; Garbit S; Kochbati E; Etienne A; Charbonnier A; Collette Y; Vey N; Olive D
    J Immunol; 2012 May; 188(9):4701-8. PubMed ID: 22467661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of Mcl-1 through GSK-3β activation contributes to arsenic trioxide-induced apoptosis in acute myeloid leukemia cells.
    Wang R; Xia L; Gabrilove J; Waxman S; Jing Y
    Leukemia; 2013 Feb; 27(2):315-24. PubMed ID: 22751450
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutively active STAT5b induces cytokine-independent growth of the acute myeloid leukemia-derived MUTZ-3 cell line and accelerates its differentiation into mature dendritic cells.
    Bontkes HJ; Ruizendaal JJ; Kramer D; Santegoets SJ; Scheper RJ; de Gruijl TD; Meijer CJ; Hooijberg E
    J Immunother; 2006; 29(2):188-200. PubMed ID: 16531819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of Toll-like receptor 4 and 7/8 agonists is necessary to generate potent blast-derived dendritic cells in Acute Myeloid Leukemia.
    Nourizadeh M; Masoumi F; Memarian A; Alimoghaddam K; Moazzeni SM; Hadjati J
    Leuk Res; 2012 Sep; 36(9):1193-9. PubMed ID: 22579107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrovirus-mediated IL-7 expression in leukemic dendritic cells generated from primary acute myelogenous leukemias enhances their functional properties.
    Bello-Fernández C; Stasakova J; Renner A; Carballido-Perrig N; Koening M; Waclavicek M; Madjic O; Oehler L; Haas O; Carballido JM; Buschle M; Knapp W
    Blood; 2003 Mar; 101(6):2184-90. PubMed ID: 12424204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.
    Grabrucker C; Liepert A; Dreyig J; Kremser A; Kroell T; Freudenreich M; Schmid C; Schweiger C; Tischer J; Kolb HJ; Schmetzer H
    J Immunother; 2010 Jun; 33(5):523-37. PubMed ID: 20463595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemia.
    Wetzler M; Andrews C; Ford LA; Tighe S; Barcos M; Sait SN; Block AW; Nowak NJ; Baer MR; Wang ES; Baumann H
    Cancer; 2011 Nov; 117(21):4861-8. PubMed ID: 21456022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiles of activation, differentiation-markers, or β-integrins on T cells contribute to predict T cells' antileukemic responses after stimulation with leukemia-derived dendritic cells.
    Vogt V; Schick J; Ansprenger C; Braeu M; Kroell T; Kraemer D; Köhne CH; Hausmann A; Buhmann R; Tischer J; Schmetzer H
    J Immunother; 2014; 37(6):331-47. PubMed ID: 24911794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of STAT3 activation in modulating the immune microenvironment of GBM.
    See AP; Han JE; Phallen J; Binder Z; Gallia G; Pan F; Jinasena D; Jackson C; Belcaid Z; Jeong SJ; Gottschalk C; Zeng J; Ruzevick J; Nicholas S; Kim Y; Albesiano E; Pardoll DM; Lim M
    J Neurooncol; 2012 Dec; 110(3):359-68. PubMed ID: 23096132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Honokiol Inhibits Constitutive and Inducible STAT3 Signaling via PU.1-Induced SHP1 Expression in Acute Myeloid Leukemia Cells.
    Bi L; Yu Z; Wu J; Yu K; Hong G; Lu Z; Gao S
    Tohoku J Exp Med; 2015 Nov; 237(3):163-72. PubMed ID: 26466521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.